BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 20812902)

  • 1. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).
    Ni Z; Bikadi Z; Rosenberg MF; Mao Q
    Curr Drug Metab; 2010 Sep; 11(7):603-17. PubMed ID: 20812902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the breast cancer resistance protein (ABCG2) in drug transport.
    Mao Q; Unadkat JD
    AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.
    Han B; Zhang JT
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):31-42. PubMed ID: 14754410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificity.
    Ni Z; Bikadi Z; Shuster DL; Zhao C; Rosenberg MF; Mao Q
    Biochemistry; 2011 Sep; 50(37):8057-66. PubMed ID: 21854076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L; Ross DD
    Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.
    Nakanishi T; Ross DD
    Chin J Cancer; 2012 Feb; 31(2):73-99. PubMed ID: 22098950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.
    Natarajan K; Xie Y; Baer MR; Ross DD
    Biochem Pharmacol; 2012 Apr; 83(8):1084-103. PubMed ID: 22248732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.
    Mao Q; Unadkat JD
    AAPS J; 2015 Jan; 17(1):65-82. PubMed ID: 25236865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of the activity and substrate recognition of breast cancer resistance protein (ABCG2).
    Szafraniec MJ; Szczygieł M; Urbanska K; Fiedor L
    Drug Metab Rev; 2014 Nov; 46(4):459-74. PubMed ID: 25036722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer resistance protein (BCRP) in acute leukemia.
    Plasschaert SL; Van Der Kolk DM; De Bont ES; Vellenga E; Kamps WA; De Vries EG
    Leuk Lymphoma; 2004 Apr; 45(4):649-54. PubMed ID: 15160935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-resistant proteins in breast cancer: recent progress in multidrug resistance].
    Wu DL; Huang F; Lu HZ
    Ai Zheng; 2003 Apr; 22(4):441-4. PubMed ID: 12704006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.
    Noguchi K; Katayama K; Mitsuhashi J; Sugimoto Y
    Adv Drug Deliv Rev; 2009 Jan; 61(1):26-33. PubMed ID: 19111841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation.
    Haimeur A; Conseil G; Deeley RG; Cole SP
    Curr Drug Metab; 2004 Feb; 5(1):21-53. PubMed ID: 14965249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance and cancer: the role of the human ABC transporter ABCG2.
    Ejendal KF; Hrycyna CA
    Curr Protein Pept Sci; 2002 Oct; 3(5):503-11. PubMed ID: 12369998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer resistance protein in pharmacokinetics and drug-drug interactions.
    Xia CQ; Yang JJ; Gan LS
    Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):595-611. PubMed ID: 16863427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3).
    Paturi DK; Kwatra D; Ananthula HK; Pal D; Mitra AK
    Int J Pharm; 2010 Jan; 384(1-2):32-8. PubMed ID: 19782742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Leslie EM; Deeley RG; Cole SP
    Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport.
    Ni Z; Bikadi Z; Cai X; Rosenberg MF; Mao Q
    Am J Physiol Cell Physiol; 2010 Nov; 299(5):C1100-9. PubMed ID: 20739628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.
    Jonker JW; Smit JW; Brinkhuis RF; Maliepaard M; Beijnen JH; Schellens JH; Schinkel AH
    J Natl Cancer Inst; 2000 Oct; 92(20):1651-6. PubMed ID: 11036110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug resistance mediated by ABC transporters].
    Yoshikawa M; Ito A; Ishikawa T; Ikegami Y
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.